pe
pep-05148 v1 CC-BY-SA-4.0

Neuromedin-B appetite & blood sugar peptide

An experimental peptide that switches on the same body signal as Ozempic-style drugs to curb appetite and steady blood sugar; not an approved medicine.

statuscomputed targetGLP-1R length32 aa refs2
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.843
pTM0.850
avg pLDDT70.1
ranking score0.729
STRUCTURE · PEP-05148 × GLP-1R
ranking0.729
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence32 aa
15101520253032
APLGWDLPESRSRASK IRVHPRGNLWATGHFM
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.8427309393882751 boltz-2
ranking score 0.7293829321861267 boltz-2
structural qualityopenfold3
metricvaluenote
gpde0.834global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Ala-Pro-Leu-Gly-Trp-Asp-Leu-Pro-Glu-Ser-Arg-Ser-Arg-Ala-Ser-Lys-Ile-Arg-Val-His-Pro-Arg-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Neuromedin-B appetite & blood sugar peptide (pep-05148, v1). PeptideModel. https://peptidemodel.com/card/pep-05148
@peptide{pep05148,
  sequence = {APLGWDLPESRSRASKIRVHPRGNLWATGHFM},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 2 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use